Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01451814 · ClinicalTrials.gov registry record · Phase 2
Development of Positive Psychotherapy for Smoking Cessation
A Phase 2 study, sponsored by Brown University.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT01451814: Completed Phase 2 study, sponsored by Brown University.
NCT01451814 is a Phase 2 study that has completed, run by Brown University. The registered enrollment target is 66 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01451814, a Phase 2 study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
The primary objective of this study is to test a manualized adaptation of positive psychotherapy (PPT) for smoking cessation (PPT-S). The investigators will conduct a preliminary randomized clinical trial (N = 80) to examine the feasibility, acceptability, and efficacy of PPT-S over 26 weeks of follow up in comparison to a standard smoking cessation treatment. Both treatments will be delivered in individual 6 sessions over 6 weeks, and will include provision of transdermal nicotine patch. The effect size estimates from this Stage 1b research will provide the foundation for a future application to conduct a large-scale, Stage II, randomized clinical trial.
Primary Outcome
Biochemically verified abstinence from smoking over the past 7 days
Interventions
- BEHAVIORAL Relaxation training
- DRUG Nicotine polacrilex
- BEHAVIORAL Positive Psychotherapy for smoking cessation
- BEHAVIORAL Behavioral smoking cessation treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-02 |
| Phase | Phase 2 |
What the finished NCT01451814 record still lists
NCT01451814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 4 interventions - of which Relaxation training is the first listed.
NCT01451814 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01451814 about?
NCT01451814 is a clinical study titled "Development of Positive Psychotherapy for Smoking Cessation". The primary objective of this study is to test a manualized adaptation of positive psychotherapy (PPT) for smoking cessation (PPT-S). The investigators will conduct a preliminary randomized clinical trial (N = 80) to examine the feasibility, acceptability, and efficacy of PPT-S over 26 weeks of foll...
What is the current status of trial NCT01451814?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2011-10. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01451814?
The interventions under investigation include: Relaxation training (BEHAVIORAL), Nicotine polacrilex (DRUG), Positive Psychotherapy for smoking cessation (BEHAVIORAL), Behavioral smoking cessation treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01451814?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01451814's enrollment target sits among peer trials
66 975th of 2000 higher than 1,014 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia